Literature DB >> 6154664

Multiple antigenic specificities within primary 3-methylcholanthrene-induced rat sarcomas and metastases.

M V Pimm, M J Embleton, R W Baldwin.   

Abstract

Sarcomas were induced in WAB/Not rats by subcutaneous injection of 10, 5 or 1 mg 3-methylcholanthrene (MCA) but not by 0.1 mg. Although tumours appeared earlier in rats given 10 mg MCA, compared with 1 mg, the majority of transplant lines from primary tumours were immunogenic and there was no correlation between the inducing dose of carcinogen and the growth characteristics or immunogenicities of the transplant lines. Most importantly sublines established from opposite poles of primary sarcomas were antigenically distinct in a substantial portion of cases, indicating that the primary tumours consisted of antigenically heterogeneous populations of cells. Furthermore, with one rat, renal and pulmonary metastases were antigenically distinct from a peritoneal secondary and the primary growth. These findings indicate that primary carcinogen-induced tumours may be polyclonal in origin and this has implications for both the understanding of the carcinogenic process, and for the immunotherapy of malignant disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154664     DOI: 10.1002/ijc.2910250512

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity. Their immunologic and metastatic characterization.

Authors:  J R Starkey; W C Davis; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

Review 2.  Manipulation of host resistance in cancer therapy.

Authors:  R W Baldwin
Journal:  Springer Semin Immunopathol       Date:  1982

Review 3.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

4.  The selective nature of metastasis.

Authors:  J E Talmadge
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  Syngeneic humoral immune responses to tumor-associated antigens expressed by K-1735 UV-induced melanoma and its metastases.

Authors:  P Thistlethwaithe; D D Davidson; I J Fidler; J A Roth
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  Immunogenicity of cellular and acellular antigen preparations from a methylcholanthrene-induced mouse sarcoma.

Authors:  K Höffken; U Steih; C G Schmidt
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

Review 7.  Intratumor immunologic heterogeneity.

Authors:  F R Miller
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

Review 8.  Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cells.

Authors:  G Parmiani; G Fossati; D Taramelli; A Anichini; A Balsari; C Gambacorti-Passerini; G Sciorelli; N Cascinelli
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

9.  Murine models of metastatic neoplasia to the central nervous system.

Authors:  F K Conley
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

10.  Specificity of tumour associated transplantation antigens (TATA) of different clones from the same tumour.

Authors:  M F Woodruff; J D Ansell; B A Hodson; H S Micklem
Journal:  Br J Cancer       Date:  1984-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.